Browsing: GSK

GSK, the UK’s second-biggest drugmaker, has unveiled a $2.2bn (£1.6bn) deal to acquire a Californian biotech company which is developing a drug to protect against severe…

That’s gratitude, eh? It’s not even a fortnight since the government agreed to raise the prices the NHS pays for new medicines and here comes the…

The chief executive of GSK declared yesterday that the USis the best place for pharmaceutical companies to invest.Emma Walmsley said the US led the world in…

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Strong growth in speciality medicines for cancers and…